APA

Frey S. E., Shakib S., Chanthavanich P., Richmond P., Smith T., Tantawichien T., Kittel C., Jaehnig P., Mojares Z., Verma B., Kanesa-Thasan N. & Hohenboken M. (2019). Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. : Open forum infectious diseases.

Chicago

Frey Sharon E, Shakib Sepehr, Chanthavanich Pornthep, Richmond Peter, Smith Timothy, Tantawichien Terapong, Kittel Claudia, Jaehnig Peter, Mojares Zenaida, Verma Bikash, Kanesa-Thasan Niranjan and Hohenboken Matthew. 2019. Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. : Open forum infectious diseases.

Harvard

Frey S. E., Shakib S., Chanthavanich P., Richmond P., Smith T., Tantawichien T., Kittel C., Jaehnig P., Mojares Z., Verma B., Kanesa-Thasan N. and Hohenboken M. (2019). Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. : Open forum infectious diseases.

MLA

Frey Sharon E, Shakib Sepehr, Chanthavanich Pornthep, Richmond Peter, Smith Timothy, Tantawichien Terapong, Kittel Claudia, Jaehnig Peter, Mojares Zenaida, Verma Bikash, Kanesa-Thasan Niranjan and Hohenboken Matthew. Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. : Open forum infectious diseases. 2019.